rofecoxib has been researched along with Lupus Erythematosus, Systemic in 2 studies
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, S | 1 |
| Tambar, S | 1 |
| Chohan, S | 1 |
| Ramsey-Goldman, R | 1 |
| Lee, C | 1 |
| Hersh, AO | 1 |
| von Scheven, E | 1 |
| Yazdany, J | 1 |
| Panopalis, P | 1 |
| Trupin, L | 1 |
| Julian, L | 1 |
| Katz, P | 1 |
| Criswell, LA | 1 |
| Yelin, E | 1 |
2 other studies available for rofecoxib and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Acute myocardial infarction after treatment of thrombocytopenia in a young woman with systemic lupus erythematosus.
Topics: Antibodies, Antiphospholipid; Cyclooxygenase Inhibitors; Female; Humans; Immunoglobulins, Intravenou | 2008 |
Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Biopsy; Celecoxib; Female; Follow | 2009 |